Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Industry Sees Harmonization Opportunities In High-level U.S.-EU Trade Talks

This article was originally published in The Gray Sheet

Executive Summary

Official negotiations between the U.S. and EU on the Transatlantic Trade and Investment Partnership trade agreement began last week. Medical device industry associations representing both regions want the harmonization of U.S. and EU device industry regulations to be part of the agreement.

You may also be interested in...



European Union Finally Joins MDSAP Work Group – But Only As Observers

The European Commission sent representatives to a March 23 meeting related to IMDRF's Medical Device Single Audit Program. But for now they'll only be observing, FDA's Kim Trautman says.

Europe Urges Greater Alignment On U.S. And EU Device Review

The European Commission issued proposals for the next round of Transatlantic Trade and Investment Partnership talks, including support for a common device approval application for Europe and the U.S.

News Briefs: Panel Supports Cochlear Implant; ReShape Duo Trial Update; Medtronic’s D-fib Lead Software

FDA panel supports cochlear implant device. ReShape Medical’s ReShape Duo intragastric balloon meets its primary efficacy endpoints in the REDUCE trial. Medtronic gains FDA approval of defibrillator lead software. More news.

Related Content

Topics

UsernamePublicRestriction

Register

LL1133148

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel